By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Benzodiazepine > Oxazepam

Oxazepam

GMJ
Last updated: 02/06/2026 14:30
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|622 words

Oxazepam Drug Profile

What is Oxazepam?

Oxazepam is a benzodiazepine medication primarily used to treat anxiety disorders and alcohol withdrawal symptoms. As a member of the benzodiazepine class, it works by enhancing the calming effects of a natural brain chemical called GABA. Oxazepam is considered a short-to-intermediate acting benzodiazepine with a relatively safer profile compared to some other drugs in its class.

Uses

Oxazepam is approved for several therapeutic purposes:

  • Anxiety disorders: Used to manage symptoms of generalized anxiety disorder and other anxiety-related conditions, providing short-term relief from excessive worry and tension
  • Alcohol withdrawal: Helps manage withdrawal symptoms in people discontinuing alcohol use, including tremors, agitation, and seizure prevention
  • Anxiety associated with depression: May be prescribed alongside antidepressants to address anxiety symptoms that occur with depressive disorders
  • Muscle tension: Can provide relief from muscle spasms and tension related to anxiety or stress
  • Sleep disturbances: Sometimes used short-term for insomnia related to anxiety, though this is not its primary indication

How it works

Oxazepam enhances the activity of gamma-aminobutyric acid (GABA), the brain’s primary inhibitory neurotransmitter. It binds to specific GABA receptors in the brain, increasing GABA’s calming effects and reducing excessive electrical activity in nerve cells. This results in decreased anxiety, muscle relaxation, and sedation.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Drowsiness and fatigue
  • Dizziness and lightheadedness
  • Confusion, especially in elderly patients
  • Unsteadiness or coordination problems
  • Memory impairment
  • Headache
  • Nausea
  • Changes in appetite

Serious side effects requiring immediate medical attention:

  • Severe allergic reactions with rash, swelling, or difficulty breathing
  • Significant mood changes, including depression or suicidal thoughts
  • Severe confusion or memory loss
  • Difficulty breathing or slow/irregular heartbeat
  • Unusual muscle movements or tremors

Warnings and precautions

  • Dependency risk: Oxazepam can be habit-forming, and physical dependence may develop with prolonged use. Abrupt discontinuation can cause withdrawal symptoms including seizures.
  • Pregnancy and breastfeeding: Classified as pregnancy category D, meaning it may harm an unborn baby. It passes into breast milk and should be avoided during breastfeeding unless benefits clearly outweigh risks.
  • Elderly patients: Older adults are more sensitive to benzodiazepines and face increased risk of falls, confusion, and cognitive impairment. Lower doses are typically recommended.
  • Liver function: While oxazepam is considered safer than some benzodiazepines in patients with liver problems, caution is still needed in severe liver disease.
  • Respiratory conditions: Should be used cautiously in patients with sleep apnea, chronic obstructive pulmonary disease, or other breathing problems due to respiratory depression risk.

Interactions

  • Alcohol: Significantly increases sedation and respiratory depression risk; combination can be fatal
  • Opioid pain medications: Combined use dramatically increases risk of severe sedation, respiratory depression, and death
  • Other benzodiazepines: Additive effects increase risk of excessive sedation and respiratory problems
  • Antihistamines: May enhance drowsiness and cognitive impairment
  • Muscle relaxants: Increased risk of excessive sedation and muscle weakness
  • Antidepressants: Some antidepressants may increase oxazepam levels or enhance sedative effects
  • Anticonvulsants: May have additive sedative effects and potentially alter seizure thresholds
  • Digoxin: Oxazepam may increase digoxin levels, requiring monitoring

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosages vary based on the condition being treated:

  • Anxiety: 10-30 mg taken 3-4 times daily
  • Alcohol withdrawal: 15-30 mg taken 3-4 times daily
  • Elderly or debilitated patients: Initial dose of 10 mg three times daily, with careful upward adjustment as needed

Treatment duration should generally be limited to 2-4 weeks to minimize dependency risk. Dosages must be individualized based on patient response, age, and medical conditions. Healthcare providers should determine the lowest effective dose and monitor for signs of tolerance or dependence. Gradual dose reduction is essential when discontinuing treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Oxazepam." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/oxazepam/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
Traditional Chinese herb shows promise for androgenetic alopecia treatment

Traditional Chinese herb Polygonum multiflorum shows promise for treating androgenetic alopecia through…

Dual Doctor Couples Face Amplified Childcare Crisis in Medical Training

Dual doctor couples face amplified childcare challenges during medical training, with foundation…

Child Mortality Progress Stalls: 60 Countries Risk Missing 2030 UN Targets

New BMJ analysis reveals 60 countries unlikely to meet UN child survival…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Clonazepam

By
Prof. Giorgi Pkhakadze
02/06/2026

Temazepam

By
Prof. Giorgi Pkhakadze
02/06/2026

Lorazepam

By
Prof. Giorgi Pkhakadze
02/06/2026

Diazepam

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up